7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Demonstration Activities for the clinical validation of the prototype HILYSENS Lab-on-a-Chip (HILYSENS II)
Date du début: 1 avr. 2014, Date de fin: 31 mars 2016,
HILYSENS II is based on the 2-year HILYSENS research and development project (started November 2010) funded by the ‘Research for the Benefit of SMEs’ program of the European Commission's Seventh Framework Programme (FP7). HILYSENS II proposes Demonstration Activities for the prototype HILYSENS Lab-on-a-Chip developed during the successful research and development project, which was designed as a s ...
Voir le projet
5
Participants partenaires
TERMINÉ
Chemotherapy guidance based on efficacy of treatment regimen in cancer cells from the individual patient (CHEMOGUIDE)
Date du début: 1 avr. 2013, Date de fin: 30 juin 2015,
The ChemoGuide project will clinically validate a proto-type technology (2treat) developed in the previous “Research for SMEs” project, “Integrated Chemical Synthesis and Cell screening in patient cells (ICSC). The project will execute a clinical study to evaluate the 2treat test’s capability of predicting which combination therapy that is most efficacious and show no resistance in the individual ...
Voir le projet
5
Participants partenaires
TERMINÉ
Point-of-care blood device for fast and reliable prediction of drug response in non- small-cell lung carcinoma patients from blood samples (LungCARD)
Date du début: 7 févr. 2013, Date de fin: 6 févr. 2015,
Chemotherapy is the standard care for the treatment of non-small cell lung carcinoma (NSCLC) patients, however most of non-small cell lung cancer tumours are not sensitive to this treatment. As an alternative to chemoterapy, target therapy with gefitinib (epidermal growth factor receptor-tyrosine kinase inhibitor) has been used in clinical practice in patients with tumours harbouring mutations in ...
Voir le projet
7
Participants partenaires
TERMINÉ
Laboratory Skin Patches and SmartCards based on foils and compatible with a smartphone (LabOnFoil)
Date du début: 1 mai 2008, Date de fin: 28 févr. 2013,
Conventional analytical methods often require a large sample volume and complicated time-consuming protocols. The objective of this project is to develop ultra low cost laboratories on chips (LOC) without penalisation in time response, sensitivity or simplicity of use. The user will obtain the test results using a very popular interface (a smartphone) and a set of Labcards and Skin Patches where t ...
Voir le projet
16
Participants partenaires
TERMINÉ
Highly sensitive and specific low-cost lab-on-a-chip system for Lyme disease diagnosis (HILYSENS)
Date du début: 1 nov. 2010, Date de fin: 28 févr. 2013,
"The aim of HILYSENS is to develop a novel lab-on-chip diagnostic tool to improve clinical diagnostic, disease monitoring and treatment of Lyme Disease by enabling specific and sensitive detection of the human serological response against its causative agent Borrelia burgdoferi infections. Lyme Disease is the most common tick-borne infection in Europe with around 85,000 new cases per year and its ...
Voir le projet
8
Participants partenaires
TERMINÉ
Development of a Point of Care microfluidic chip unit and self-sampling device for cervical cancer screening and platform technology for Nucleic Acid Detection at the Point of Care (SelfPOCNAD)
Date du début: 1 oct. 2010, Date de fin: 31 déc. 2012,
In SelfPOCNAD, we propose to develop an industrial prototype for a rapid (“same day”) Cervical Cancer screening of self-taken patient samples. The industrial prototype will only include enough sample from the self-taken sample in order not to risk any clogging of the sample preparation chip. The first industrial prototype will include the detection of oncogenic E6/E7 mRNA from in total 9 HPV types ...
Voir le projet
8
Participants partenaires
TERMINÉ
Integrated Chemical synthesis and Screening in patient Cells (ICSC)
Date du début: 1 mars 2009, Date de fin: 31 août 2011,
"The ICSC project is a “Research for SMEs” focused research project that is to develop an integrated high throughput chemical synthesis and cell-based screening platform for the development of efficacious novel drug candidates without the need for chemical nor cell biological infrastructure. The technology will put early drug discovery in the hands of institutions that have a comprehensive knowled ...
Voir le projet